GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Enorama Pharma ERMA.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.76

-4.75%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 2.7m

FY2016FY2025

Net income

−SEK 75.1m

FY2016FY2025

Free cash flow

−SEK 118.5m

FY2016FY2025

Shareholders' equity

−SEK 23.5m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 2.7mSEK 15.8mSEK 1.4mSEK 6.8mSEK 11.0mSEK 2.1mSEK 7.6mSEK 5.3mSEK 1.6mSEK 4.0m
Research and development—SEK 20.0mSEK 2.9mSEK 2.9mSEK 1.8mSEK 393,000——SEK 3.7mSEK 4.0m
Operating income−SEK 62.8m−SEK 47.5m−SEK 43.7m−SEK 40.8m−SEK 26.9m−SEK 23.0m−SEK 22.9m−SEK 15.5m−SEK 7.9m−SEK 7.7m
Net income−SEK 75.1m−SEK 43.8m−SEK 44.6m−SEK 41.8m−SEK 28.5m−SEK 23.9m−SEK 24.7m−SEK 16.3m−SEK 8.8m−SEK 7.8m
Diluted earnings per share-1.01-0.72-0.93-4.18-4.17-4.32-4.60-3.32-1.90-1.72

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 8.3mSEK 15.9mSEK 34.4mSEK 48.7mSEK 50.9mSEK 40.9mSEK 42.6mSEK 38.8mSEK 15.5mSEK 13.6m
Cash and short-term investmentsSEK 3.0mSEK 2.1mSEK 6.2mSEK 4.1mSEK 12.2mSEK 4.7mSEK 14.6mSEK 16.4mSEK 164,760SEK 3.8m
Total liabilitiesSEK 31.7mSEK 8.1mSEK 14.8mSEK 17.2mSEK 29.6mSEK 39.1mSEK 35.4mSEK 21.8mSEK 8.1mSEK 4.5m
Debt——SEK 436,000SEK 1.9mSEK 3.8mSEK 5.7mSEK 25.0mSEK 1.6mSEK 3.3mSEK 3.5m
Shareholders' equity−SEK 23.5mSEK 7.8mSEK 19.5mSEK 31.5mSEK 21.4mSEK 1.8mSEK 7.2mSEK 17.0mSEK 7.4mSEK 9.1m
Shares outstanding75m60m48m10m7m6m5m5m5m5m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 59.3m−SEK 35.7m−SEK 41.3m−SEK 33.0m−SEK 30.2m−SEK 23.0m−SEK 26.6m−SEK 13.4m−SEK 6.7m−SEK 6.1m
Capital spending−SEK 59.3m———−SEK 1.8m−SEK 3.8m−SEK 4.2m−SEK 7.2m−SEK 3.7m−SEK 4.0m
Free cash flow−SEK 118.5m−SEK 35.7m−SEK 41.3m−SEK 33.0m−SEK 32.0m−SEK 26.8m−SEK 30.7m−SEK 20.5m−SEK 10.4m−SEK 10.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue—−SEK 109,000SEK 1.8m−SEK 193,000SEK 733,000SEK 449,000SEK 2.6mSEK 7.5m
Operating income−SEK 11.7m−SEK 12.1m−SEK 18.5m−SEK 12.3m−SEK 15.3m−SEK 16.7m−SEK 26.7m−SEK 4.5m
Net income−SEK 13.1m−SEK 12.6m−SEK 20.6m−SEK 13.3m−SEK 18.7m−SEK 22.5m−SEK 22.0m−SEK 7.1m
Diluted earnings per share-0.18-0.17-0.28-0.18-0.25-0.30-0.36-0.12
Cash from operations−SEK 14.0m−SEK 12.0m−SEK 14.0m−SEK 11.0m−SEK 7.0m−SEK 26.0m−SEK 3.0m−SEK 9.0m
Capital spending——−SEK 14.0m—————
Free cash flow——−SEK 28.0m—————
Total assetsSEK 7.0mSEK 22.9mSEK 8.3mSEK 12.6mSEK 25.0mSEK 35.4mSEK 15.9mSEK 41.5m
Cash and short-term investmentsSEK 2.1mSEK 17.8mSEK 3.0mSEK 6.6mSEK 2.5mSEK 4.6mSEK 2.1mSEK 9.6m
Debt———————SEK 333,000
Shareholders' equity−SEK 50.4m−SEK 36.6m−SEK 23.5m−SEK 4.6mSEK 8.3mSEK 9.3mSEK 7.8mSEK 33.7m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-26.3%5.0%3.2%
Operating income15.5%22.2%60.3%
Net income21.6%25.7%60.7%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-596.1%-729.3%-613.5%-496.1%
Net margin-642.7%-768.7%-646.2%-524.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-1.1-2.8-2.0-0.5-3.2-4.6-5.3-10.7-24.8-3.1
Price to sales31.37.866.03.28.351.417.233.2138.06.1

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.